Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association
- PMID: 29632217
- DOI: 10.1161/CIR.0000000000000570
Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association
Abstract
Introduction: In a recent report, the American Heart Association estimated that medical costs and productivity losses of cardiovascular disease (CVD) are expected to grow from $555 billion in 2015 to $1.1 trillion in 2035. Although the burden is significant, the estimate does not include the costs of family, informal, or unpaid caregiving provided to patients with CVD. In this analysis, we estimated projections of costs of informal caregiving attributable to CVD for 2015 to 2035.
Methods: We used data from the 2014 Health and Retirement Survey to estimate hours of informal caregiving for individuals with CVD by age/sex/race using a zero-inflated binomial model and controlling for sociodemographic factors and health conditions. Costs of informal caregiving were estimated separately for hypertension, coronary heart disease, heart failure, stroke, and other heart disease. We analyzed data from a nationally representative sample of 16 731 noninstitutionalized adults ≥54 years of age. The value of caregiving hours was monetized by the use of home health aide workers' wages. The per-person costs were multiplied by census population counts to estimate nation-level costs and to be consistent with other American Heart Association analyses of burden of CVD, and the costs were projected from 2015 through 2035, assuming that within each age/sex/racial group, CVD prevalence and caregiving hours remain constant.
Results: The costs of informal caregiving for patients with CVD were estimated to be $61 billion in 2015 and are projected to increase to $128 billion in 2035. Costs of informal caregiving of patients with stroke constitute more than half of the total costs of CVD informal caregiving ($31 billion in 2015 and $66 billion in 2035). By age, costs are the highest among those 65 to 79 years of age in 2015 but are expected to be surpassed by costs among those ≥80 years of age by 2035. Costs of informal caregiving for patients with CVD represent an additional 11% of medical and productivity costs attributable to CVD.
Conclusions: The burden of informal caregiving for patients with CVD is significant; accounting for these costs increases total CVD costs to $616 billion in 2015 and $1.2 trillion in 2035. These estimates have important research and policy implications, and they may be used to guide policy development to reduce the burden of CVD on patients and their caregivers.
Keywords: AHA Scientific Statements; cardiovascular diseases; caregivers; cost of illness.
© 2018 American Heart Association, Inc.
Conflict of interest statement
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
Similar articles
-
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.Circulation. 2011 Mar 1;123(8):933-44. doi: 10.1161/CIR.0b013e31820a55f5. Epub 2011 Jan 24. Circulation. 2011. PMID: 21262990
-
Cost of cardiovascular diseases in the United Kingdom.Heart. 2006 Oct;92(10):1384-9. doi: 10.1136/hrt.2005.072173. Epub 2006 May 15. Heart. 2006. PMID: 16702172 Free PMC article.
-
Cost of informal caregiving for patients with heart failure.Am Heart J. 2015 Jan;169(1):142-48.e2. doi: 10.1016/j.ahj.2014.10.010. Epub 2014 Oct 25. Am Heart J. 2015. PMID: 25497259 Free PMC article.
-
Modeling costs and burden of informal caregiving for persons with bipolar disorder.J Ment Health Policy Econ. 2006 Jun;9(2):99-110. J Ment Health Policy Econ. 2006. PMID: 17007487
-
Cost of informal care for patients with cardiovascular disease or diabetes: current evidence and research challenges.Qual Life Res. 2017 Jun;26(6):1379-1386. doi: 10.1007/s11136-016-1478-0. Epub 2016 Dec 19. Qual Life Res. 2017. PMID: 27995368 Free PMC article. Review.
Cited by
-
Vasorelaxant and Hypotensive Effects of Galla chinensis in Rats.Int J Mol Sci. 2024 Jul 21;25(14):7962. doi: 10.3390/ijms25147962. Int J Mol Sci. 2024. PMID: 39063203 Free PMC article.
-
Elucidating VSMC phenotypic transition mechanisms to bridge insights into cardiovascular disease implications.Front Cardiovasc Med. 2024 May 13;11:1400780. doi: 10.3389/fcvm.2024.1400780. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38803664 Free PMC article. Review.
-
Confounding Factors Responsible for Elevated Lp(a) Levels in Patients with Coronary Artery Disease.Ann Card Anaesth. 2024 Jan 1;27(1):32-36. doi: 10.4103/aca.aca_88_23. Epub 2024 Jan 12. Ann Card Anaesth. 2024. PMID: 38722118 Free PMC article.
-
Impact of including productivity costs in economic analyses of vaccines for C. difficile infections and infant respiratory syncytial virus, in a UK setting.Cost Eff Resour Alloc. 2024 Apr 30;22(1):34. doi: 10.1186/s12962-024-00533-4. Cost Eff Resour Alloc. 2024. PMID: 38689331 Free PMC article.
-
Depression Onset After a Spouse's Cardiovascular Event.JAMA Netw Open. 2024 Apr 1;7(4):e244602. doi: 10.1001/jamanetworkopen.2024.4602. JAMA Netw Open. 2024. PMID: 38607629 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical